Yáñez-Cortés EFJ

Language: Spanish
References: 20
Page: 100-107
PDF size: 171.92 Kb.

Text Extraction

No abstract

REFERENCES

1. Jaramillo MJ. Editorial. Rev Colomb Anest 2005;33(4).

2. Pandit SK. J Perianesth Nursing 1999;14:270.

3. Johnson. Healthcare Finance Management 2000;54:48.

4. Stoelting RK, Miller RD. Basics of Anesthesia. 4th ed. Philadelphia, Churchill Livingstone, 2000: 391.

5. Paul F. White and Ian Smith-Propofol. In: Paul F. White. Intravenous Anesthesia. Williams & Wilkins, 1997: 111-152.

6. Schüttler J, Ihmsen MH. Population pharmacokinetics of propofol: a multicenter study. Anesthesiology 2000;92:727-38.

7. Eger EL. Desflurane (suprane) a compendium and reference. Nutley NJ Anaquest 1993:1-119.

8. Egan TDE, Lemmens HJM, Fiset P, Hermann, DJ, Muir KT, Stanski DR, Shafer SL. The Pharmacokinetics of the new short-acting opioid remifentanyl (GI87084B) in healthy adult male volunteers. Anesthesiology 1993;79:881-892.

9. Trescot AM, Datta S, Lee M, Hansen H. Opioid pharmacology. Pain Physician Opioid Special Issue 2008;11:S133-S153.

10. Benyamin R, Tresctot AM, Datta S, Buenaventura R, Adlaka R, Sehgal N, Glaser SE, Vallejo R. Opioid complications and side effects. Pain Physician Opioid Special Issue 2008;11:S105-S120.

11. Murphy GS. Residual neuromuscular blockade: incidence, assessment, and relevance in the postoperative period. Minerva Anestesiol 2006;72:97-109.

12. Murphy GS, Szokol JW, Marymont JH, Franklin M, Avram MJ†, Vender JS. Residual paralysis at the time of tracheal extubation. Anesth Analg 2005;100:1840-5.

13. Eriksson LI, Sundman E, Olsson R, Nilsson L, Witt H, Ekberg O, Kuylenstierna R. Functional assessment of the pharynx at rest and during swallowing in partially paralyzed humans: simultaneous videomanometry and mechanomyography of awake human volunteers. Anesthesiology 1997;87:1035-43.

14. Murphy GS. Residual neuromuscular blockade: incidence, assessment, and relevance in the postoperative period. Minerva Anestesiol 2006;72:97-109.

15. Barajas R, Camarena J, Castellanos A, Castilleros OA, Castorena G, De Anda D, Hernández M, López G, López V, Oliveros Y, Ramírez R, Rendón ME, Romo A, Velarde J, Yáñez J. Determinación de la incidencia de la parálisis residual postanestésica con el uso de agentes bloqueadores neuromusculares en México. Rev Mex Anest 2011;34:181-189.

16. Kim KS, Cheong MA, Lee HJ, Lee JM. Tactile assessment for the reversibility of rocuronium-induced neuromuscular blockade during propofol or sevoflurane anesthesia. Anesth Analg 2004;99:1080-1085.

17. Gijsenbergh F, Ramael S, Houwing N, van Iersel T. First human exposure of Org 25969, a novel agent to reverse the action of rocuronium bromide. Anesthesiology 2005;103:695-703.

18. Naguib M. Sugammadex: another milestone in clinical neuromuscular pharmacology. Anesth Analg March 2007;104:575-581.

19. Pavlin DJ, Rapp SE, Polissar NL, Malmgren JA, Koerschgen M, Keyes H. Factors affecting discharge time in adult outpatients. Anesth Analg 1998;87:816-826.

20. Schlosser RJ, Steele SM. Ideal ambulatory surgery center structure and function. In: Susan M Steele, et al. Ambulatory Anesthesia Perioperative Analgesia. McGraw-Hill, 2005: 35.